SpyGlass Pharma Inc., which is promising an intraocular lens that will reshape the treatment of glaucoma, emerged from its initial public offering last month with a big boost from Wall Street.

Glaucoma is one of the most common causes of permanent blindness in the world. It slowly damages the optic nerve, which is ...

ROCHESTER, Minn., March 13, 2026 /PRNewswire/ -- Nanodropper Inc. today announced the launch of the Eye Drop Score, a first-of-its-kind self-check quiz designed to help people who rely on prescription ...

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...

An ophthalmologist and immediate past Medical Director of the Federal Medical Centre (FMC), Umuahia, Dr. Abali Chuku, has called for a concerted effort in the fight against glaucoma-related blindness, ...

Building on prior Ophthalmology Times coverage examining how ophthalmic drug shortages are both more frequent and longer-lasting than the national average, Ian Pitha, MD, PhD, an ophthalmologist at ...

If Vice President JD Vance and Dr. Mehmet Oz are serious about restoring fiscal credibility to entitlement programs, Medicaid is where reform must begin.

A Support, Educate, Empower (SEE) glaucoma coaching program improves medication adherence compared with standard written education, according to a study published online Feb. 26 in JAMA Ophthalmology.

BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 ...

This is likely due to untreated myopia in these earlier generations of Singaporeans, who did not have many treatment options in their growing-up years.

Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure.

Our role is to carefully screen each patient and help them choose the solution that best matches their lifestyle.”— Dr.